liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The ethics of implementing human papillomavirus vaccination in developed countries
Université Paris Descartes, France.ORCID-id: 0000-0003-3071-9609
Karolinska institutet, Stockholm.
University of Tampere, Finland.
University of Tampere, Finland.
Visa övriga samt affilieringar
2011 (Engelska)Ingår i: Medicine, Health care and Philosophy, ISSN 1386-7423, E-ISSN 1572-8633, Vol. 14, nr 1, s. 19-27Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Human papillomavirus (HPV) infection is the world’s most common sexually transmitted infection. It is a prerequisite for cervical cancer, the second most common cause of death in cancer among women worldwide, and is also believed to cause other anogenital and head and neck cancers. Vaccines that protect against the most common cancer-causing HPV types have recently become available, and different countries have taken different approaches to implementing vaccination. This paper examines the ethics of alternative HPV vaccination strategies. It devotes particular attention to the major arguments for and against one strategy: voluntary, publicly funded vaccination for all adolescent boys and girls. This approach seems attractive because it would protect more people against cervical cancer and other HPV-related cancers than less inclusive alternatives, without the sacrifice of autonomy that a comparably broad compulsory programme would require. Also, the herd immunity that it would likely generate would protect those who remain unvaccinated, a major advantage from a justice perspective. However, there is a possibility that a HPV vaccination programme targeting all adolescents of both sexes is not considered sufficiently cost-effective. Also, it might pose more difficulties for achieving informed consent than comparable vaccination programmes against other diseases. Ultimately, society’s choice of HPV vaccination strategy requires careful consideration not only of the values at stake but also of available and emerging scientific evidence.

Ort, förlag, år, upplaga, sidor
2011. Vol. 14, nr 1, s. 19-27
Nyckelord [en]
Ethics, Cervical cancer, Herd immunity, Human papillomavirus, Vaccination
Nationell ämneskategori
Medicinsk etik
Identifikatorer
URN: urn:nbn:se:liu:diva-77794DOI: 10.1007/s11019-010-9285-9OAI: oai:DiVA.org:liu-77794DiVA, id: diva2:529294
Tillgänglig från: 2012-05-29 Skapad: 2012-05-29 Senast uppdaterad: 2017-12-07

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltexthttp://www.springerlink.com/content/84608m78l2560125/

Personposter BETA

Malmqvist, Erik

Sök vidare i DiVA

Av författaren/redaktören
Malmqvist, Erik
I samma tidskrift
Medicine, Health care and Philosophy
Medicinsk etik

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 220 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf